Bal Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Bal Pharma has a total shareholder equity of ₹632.0M and total debt of ₹1.4B, which brings its debt-to-equity ratio to 223.2%. Its total assets and total liabilities are ₹3.3B and ₹2.7B respectively. Bal Pharma's EBIT is ₹215.3M making its interest coverage ratio 1.6. It has cash and short-term investments of ₹83.8M.
Key information
223.2%
Debt to equity ratio
₹1.41b
Debt
Interest coverage ratio | 1.6x |
Cash | ₹83.79m |
Equity | ₹632.03m |
Total liabilities | ₹2.67b |
Total assets | ₹3.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524824's short term assets (₹2.4B) exceed its short term liabilities (₹2.3B).
Long Term Liabilities: 524824's short term assets (₹2.4B) exceed its long term liabilities (₹380.5M).
Debt to Equity History and Analysis
Debt Level: 524824's net debt to equity ratio (209.9%) is considered high.
Reducing Debt: 524824's debt to equity ratio has increased from 207.1% to 223.2% over the past 5 years.
Debt Coverage: 524824's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 524824's interest payments on its debt are not well covered by EBIT (1.6x coverage).